USA - NASDAQ:AVAH - US05356F1057 - Common Stock
The current stock price of AVAH is 8.75 USD. In the past month the price increased by 1.16%. In the past year, price increased by 50.09%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.53 | 100.19B | ||
| CI | THE CIGNA GROUP | 9.31 | 70.62B | ||
| LH | LABCORP HOLDINGS INC | 15.97 | 21.00B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.39 | 20.07B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.32 | 19.93B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.06B | ||
| HIMS | HIMS & HERS HEALTH INC | 75.98 | 9.27B | ||
| DVA | DAVITA INC | 13.4 | 8.84B | ||
| CHE | CHEMED CORP | 19.76 | 6.33B | ||
| RDNT | RADNET INC | 217.53 | 6.02B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.49 | 5.87B | ||
| OPCH | OPTION CARE HEALTH INC | 18.56 | 4.49B |
Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. The company is headquartered in Atlanta, Georgia and currently employs 3,500 full-time employees. The company went IPO on 2021-04-29. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The company also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
AVEANNA HEALTHCARE HOLDINGS
400 Interstate North Parkway, Ste 1700
Atlanta GEORGIA 30339 US
CEO: Tony Strange
Employees: 3500
Phone: 17704411580
Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. The company is headquartered in Atlanta, Georgia and currently employs 3,500 full-time employees. The company went IPO on 2021-04-29. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The company also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
The current stock price of AVAH is 8.75 USD. The price increased by 1.39% in the last trading session.
AVAH does not pay a dividend.
AVAH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
AVAH stock is listed on the Nasdaq exchange.
The Revenue of AVEANNA HEALTHCARE HOLDINGS (AVAH) is expected to grow by 16.19% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
AVEANNA HEALTHCARE HOLDINGS (AVAH) will report earnings on 2026-03-11, after the market close.
ChartMill assigns a technical rating of 9 / 10 to AVAH. When comparing the yearly performance of all stocks, AVAH is one of the better performing stocks in the market, outperforming 92.43% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to AVAH. While AVAH is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months AVAH reported a non-GAAP Earnings per Share(EPS) of 0.48. The EPS increased by 2500% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.85% | ||
| ROA | 1.05% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
15 analysts have analysed AVAH and the average price target is 10.14 USD. This implies a price increase of 15.84% is expected in the next year compared to the current price of 8.75.
For the next year, analysts expect an EPS growth of 849.27% and a revenue growth 16.19% for AVAH